Skip to main content

Die Stoffwechselwirkungen des Glukagon

  • Chapter
Diabetes mellitus · A

Part of the book series: Handbuch der inneren Medizin ((INNEREN 7,volume 7 / 2 / A))

  • 52 Accesses

Zusammenfassung

Glukagon, der hyperglykämisierende glykogenolytische Faktor des Pankreas, wurde fast zur selben Zeit wie das Insulin entdeckt, nämlich vor ungefähr 5 Jahrzehnten. Kimball und Murlin (1923) trennten als erste eine hyperglykämisierende Substanz aus Insulinpräparaten ab, die sie Glukagon nannten. Neben vielen anderen haben de Duve (1953) und Bergen und van Itallie (1960) die Geschichte der Glukagonforschung ausführlich beschrieben. Während der 20 Jahre, die seiner Entdeckung folgten, kamen nur wenig neue Erkenntnisse über das Glukagon hinzu. Manche Forscher, wie Bürger u. Brandt (1935) glaubten an seine Existenz und versuchten, das Glukagon in reiner Form darzustellen. Demgegenüber schrieben andere die hyperglykämisierenden und glykogenolytischen Wirkungen der Pankreasextrakte und einiger Insulinpräparate dem Insulin selbst oder der Anwesenheit von heterogenen Verunreinigungen zu. Erst in den fünfziger Jahren trat die Arbeit über das Glukagon in eine neue Phase, als Sutherland u. de Duve (1948) und Sutherland et al. (1949) den hyperglykämisierenden Faktor aus dem Pankreas extrahierten und begannen, seine Eigenschaften zu untersuchen. Seitdem ist eine Fülle von Informationen über die verschiedenen metabolischen Wirkungen und den Wirkungsmechanismus dieses Peptids gesammelt worden. Trotzdem war es lange Zeit schwierig, die Stellung des Glukagon als Hormon und seine physiologische Rolle zu definieren, insbesondere beim Menschen. Dies hing hauptsächlich mit der Tatsache zusammen, daß bis vor kurzem kein definierter pathologischer Zustand einem Überschuß oder einem Defekt der Glukagonsekretion zugeordnet werden konnte.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aguilar-Parada, E., Eisentraut, A.M., Unger, R.H.: Effects of starvation on plasma pancreatic glucagon in normal man. Diabetes 18, 717–723(1969a).

    CAS  Google Scholar 

  • Aguilar-Parada, E., Eisentraut, A.M., Unger, R.H.: Pancreatic glucagon secretion in normal and diabetic subjects. Amer. J. med. Sci. 257, 415–418(1969b).

    CAS  Google Scholar 

  • Assan, R., Boillot, J.: Pancreatic glucagon and glucagon-like material in tissues and plasma from human fetuses 6-26 weeks old. Path. Biol. 21, 149–155(1973).

    CAS  Google Scholar 

  • Assan, R., Boillot, J., Attali, J.R., Soufflet, E., Ballero, G.: Diphasic glucagon release induced by arginine in the perfused rat pancreas. Nature (Lond.) New Biol. 239, 125–126(1972).

    CAS  Google Scholar 

  • Assan, R., Hautecouverture, G., Guillemant, S., Dauchy, F., Protin, P., Derot, M.: Evolution de parametres hormonaux (glucagon, Cortisol, hormone somatotrope) et energetiques (glucose, acides gras, glycerol libre) dans dix acido-cetoses diabetiques graves traitees. Path. et Biol. 17, 1095–1105(1969a).

    CAS  Google Scholar 

  • Assan, R., Rosselin, G., Dolais, J.: Effets sur la glucagonemie des perfusions et ingestions d’acides amines. Journees Annuelles de Diabetologie de l’Hotel Dieu, p. 25–41. Paris: Editions Medicales Flammarion 1967.

    Google Scholar 

  • Assan, R., Rosselin, G., Drouet, J., Dolais, J., Tchobroutsky, G.: Glucagon antibodies. Lancet 1965II, 590–591.

    Google Scholar 

  • Assan, R., Rosselin, G., Drouet, J., Dolais, J., Tchobroutsky, G., Derot, M.: Dosage radioimmunologique du glucagon plasmatique chez l’homme. Resultats preliminaries. Ann. Endocr. (Paris) 27, 690–695(1966).

    CAS  Google Scholar 

  • Assan, R., Tchobroutsky, G., Rosselin, G.: Caracterisation radioimmunologique de glucagon dans les tissus digestifs de diverses especes animales. Path. et Biol. 17, 747–755(1969b).

    CAS  Google Scholar 

  • Assan, R., Tiengo, A.: Comparaison des secretions de glucagon dans les diabetes sucres avec ou sans pancreatopathie organique acquise. Path. et Biol. 21, 17–25(1973).

    CAS  Google Scholar 

  • Balasse, E. O.: Regulation du metabolisme extra-hepatique des corps cetoniques in vivo. Bruxelles: Thesis, 1971.

    Google Scholar 

  • Baum, J., Simons, B.E., Unger, R.H., Madison, L.L.: Localization of glucagon in the alpha cells in the pancreatic islet by immunofluorescent technics. Diabetes 11, 371–374(1962).

    PubMed  CAS  Google Scholar 

  • Bencosme, S.A., Frei, J.: Relation of glucagon to A-cells of the pancreas. Proc. Soc. exp. Biol. (N.Y.) 91, 589–592(1956).

    CAS  Google Scholar 

  • Bencosme, S.A., Liepa, E., Lazarus, S.: Glucagon content of pancreatic tissue devoid of alpha cells. Proc. Soc. exp. Biol. (N.Y.) 90, 387–392(1955).

    CAS  Google Scholar 

  • Bencosme, S.A., Pease, D.C.: Electron microscopy of the pancreatic islets. Endocrinology 63, 1–13(1958).

    PubMed  CAS  Google Scholar 

  • Bergen, S.S., jr., Itallie, T.B. van: Glucagon. An interim report. Metabolism 9, 132–156(1960).

    PubMed  CAS  Google Scholar 

  • Berthet, J.: Some aspects of the glucagon problem. Amer. J. Med. 26, 703–714(1959).

    PubMed  CAS  Google Scholar 

  • Bilbrey, G.L., Faloona, G.R., White, M.G., Knockel, J.P.: Hyperglucagonemia of renal failure. J. clin. Invest. 53, 841–847(1974).

    PubMed  CAS  Google Scholar 

  • Björkman, N., Hellerström, C., Hellman, B., Petersson, B.: The cell types in the endocrine pancreas of the human fetus. Z. Zellforsch. 72, 425–445(1966).

    PubMed  Google Scholar 

  • Björkman, N., Hellman, B.: Ultrastructure of the pancreatic A2-cells in different species. In: Ultrastructure and metabolism of the pancreatic islets, S.E. Brolin, B. Hellman K. Knutson, eds., p. 131–142. New York: Pergamon Press 1964.

    Google Scholar 

  • Blackard, W. G., Andrews, S.S., Lazarus, E.J.: Effect of growth hormone deficiency on glucagon secretion. Proc. Soc. exp. Biol. (N.Y.) 143, 1042–1044(1973).

    CAS  Google Scholar 

  • Blazquez, E., Sugase, T., Blazquez, M., Foa, P. P.: The ontogeny of metabolic regulation in the rat with special reference to the development of insular function. Acta diabet. lat. 9, Suppl. 1, 13–35 (1972).

    Google Scholar 

  • Bloom, S.R., Daniel, P.M., Johnston, D.I., Ogawa, O., Pratt, O. E.: Release of glucagon induced by stress. Quart. J. exp. Physiol. 58, 99–108(1973).

    PubMed  CAS  Google Scholar 

  • Bloom, S.R., Johnston, D.I.: Failure of glucagon release of infants of diabetic mothers. Brit. med. J. 1972 IV, 453–454.

    Google Scholar 

  • Böttger, I., Dobbs, R., Faloona, G.R., Unger, R.H.: The effects of triglyceride absorption upon glucagon, insulin and gut glucagon-like immunoreactivity. J. clin. Invest. 52, 2532–2541(1973).

    PubMed  Google Scholar 

  • Böttger, I., Faloona, G.R., Unger, R.H.: The effect of calcium and other salts upon the release of glucagon-like immunoreactivity (GLI) from the gut. J. clin. Invest. 51, 831–836(1972a).

    Google Scholar 

  • Böttger, I., Schlein, E.M., Faloona, G.R., Knockel, J. P., Unger, R.H.: The effect of exercise on glucagon secretion. J. clin. Endocr. 35, 117–125(1927b).

    Google Scholar 

  • Bromer, W. W., Behrens, O.K.: Glucagon. In: Methods in hormone research, R.I. Dorfman, ed., tome II, p. 459–475. New York-London: Academic Press 1962.

    Google Scholar 

  • Bromer, W. W., Boucher, M.E., Koffenberger, J.E. jr.: Amino acid sequence of bovine glucagon. J. biol. Chem. 246, 2822–2827(1971).

    PubMed  CAS  Google Scholar 

  • Bromer, W. W., Sinn, L.G., Staub, A., Behrens, O.K.: The amino acid sequence of glucagon. Diabetes 6, 234–238(1957).

    PubMed  CAS  Google Scholar 

  • Buchanan, K.D., Vance, J. E., Aoki, T., Williams, R.H.: Rise in serum immunoreactive glucagon after intrajejunal glucose in pancreatectomized dogs. Proc. Soc. Exp. Biol. (N.Y.) 126, 813–815(1967).

    CAS  Google Scholar 

  • Buchanan, K.D., Vance, J.E., Dinstl, K., Williams, R.H.: Effect of blood glucose on glucagon secretion in anesthetized dogs. Diabetes 18, 11–18(1969a).

    CAS  Google Scholar 

  • Buchanan, K.D., Vance, J.E., Morgan, A., Williams, R.H.: Effect of pancreozymin on insulin and glucagon levels in blood and bile. Amer. J. Physiol. 215, 1293–1298(1968).

    PubMed  CAS  Google Scholar 

  • Buchanan, K.D., Vance, J.E., Wlliams, R.H.: Insulin and glucagon release from isolated islets of Langerhans. Effect of enteric factors. Diabetes 18, 381–386(1969b).

    CAS  Google Scholar 

  • Buckman, M.T., Conway, M.J., Seibel, J.A., Eaton, R.P.: Effect of fasting on alanine-stimulated insulin and glucagon secretion. Metabolism 22, 1253–1262(1973).

    PubMed  CAS  Google Scholar 

  • Bürger, M., Brandt, W.: Über das Glukagon (die hyperglykamisierende Substanz des Pankreas). Z. ges. exp. Med. 96, 375–397(1935).

    Google Scholar 

  • Cavallero, C.: Etudes sur le facteur hyperglycemias du pancreas (glucagon). Rev. canad. Biol. 12, 509–529(1953).

    PubMed  CAS  Google Scholar 

  • Chesney, T.M., Schofield, J. G.: Studies on the secretion of pancreatic glucagon. Diabetes 18, 627–632(1969).

    PubMed  CAS  Google Scholar 

  • Crooks, R.J.M., Hulsmans, H.A.M., Israel, D.E., Hackeng, W.H.L., Schopman, W.: Glucagonoma as part of the polyglandular adenoma syndrome. Amer. J. Med. 52, 690–698(1972).

    Google Scholar 

  • Day, J.L., Knight, M., Condon, J. R.: The role of pancreatic glucagon in the pathogenesis of acute pancreatitis. Clin. Sci. 43, 597–603(1972).

    PubMed  CAS  Google Scholar 

  • Dupre, J., Curtis, J. D., Unger, R.H., Waddell, R. W., Beck, J. C.: Effects of secretin, pancreozymin or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man. J. clin. Invest. 48, 745–757(1969).

    PubMed  CAS  Google Scholar 

  • Duve, C.de: Glucagon, the hyperglycaemic glycogenolytic factor of the pancreas. Lancet 1953 II, 99–104.

    Google Scholar 

  • Edwards, J. C., Howell, S.L., Taylor, K. W.: Fatty acids as regulators of glucagon secretion. Nature (Lond.) 224, 808–809(1969).

    CAS  Google Scholar 

  • Edwards, J. C., Taylor, K. W.: Fatty acids and the release of glucagon from isolated guinea-pig islets of Langerhans incubated in vitro. Biochim. biophys. Acta (Amst.) 215, 310–315(1970).

    CAS  Google Scholar 

  • Eisentraut, A.M., Whissen, N., Unger, R.H.: Incubation damage in the radioimmunoassay for human plasma glucagon and its prevention with “Trasylol”. Amer. J. med. Sci. 225, 137–142(1968).

    Google Scholar 

  • Exton, J. E., Park, C.R.: The stimulation of gluconeogenesis from lactate by epinephrine, glucagon, and cyclic 3′,5′-adenylate in the perfused rat liver. Pharmacol. Rev. 18, 181–188(1966).

    PubMed  CAS  Google Scholar 

  • Faller, A.: Elektronenmikroskopische Differenzierung verschiedener Inselzelltypen im Pankreas normaler Albinoratten. Z. Zellforsch. 97, 226–248(1969).

    PubMed  CAS  Google Scholar 

  • Farmer, R. W., Pelizzari, E.D., Fabre, L.F., jr., Nonaka, K., Sugase, T., Foa, P. P.: Failure of growth hormone to stimulate glucagon secretion. Proc. Soc. exp. Biol. (N.Y.) 138, 491–493(1971).

    CAS  Google Scholar 

  • Felig, P., Pozefsky, T., Marliss, E., Cahill, G.F., jr.: Alanine: key role in gluconeogenesis. Science 167, 1003–1004(1970).

    PubMed  CAS  Google Scholar 

  • Felig, P., Wahren, J., Hendler, R., Ahlborg, G.: Plasma glucagon levels in exercising man. New. Engl. J. Med. 287, 184–185(1972).

    PubMed  CAS  Google Scholar 

  • Foa, P.P., Galansino, G., Pozza, G.: Glucagon, a second pancreatic hormone. Recent Progr. Hormone Res. 13, 473–510(1957).

    PubMed  CAS  Google Scholar 

  • Fussgänger, R.D., Straub, K., Goberna, R., Jaros, P., Schröder, K.E., Raptis, S., Pfeiffer, E.F.: Primary secretion of insulin and secondary release of glucagon from the isolated perfused rat pancreas following stimulation with pancreozymin. Horm. Metab. Res. 1, 224–227(1969).

    PubMed  Google Scholar 

  • Gaede, K., Ferner, H., Kastrup, H.: Über das zweite Kohlenhydratstoffwechselhormon der Bauch speicheldrüse (Glucagon) und seine Herkunft aus dem a-Zellensystem. Klin. Wschr. 28, 388–393(1950).

    PubMed  CAS  Google Scholar 

  • Galloway, J. A.: The pharmacology and clinical use of glucagon. In: Glucagon, molecular physiology, clinical and therapeutic implication, P.J. Lefebvre and R.H. Unger, eds., p. 299–318. Oxford: Pergamon Press 1972.

    Google Scholar 

  • Gerich, J.E., Karam, J.H., Forscham, P.H.: Stimulation of glucagon secretion by epinephrine in man. J. clin. Endocr. 37, 479–480(1973a).

    CAS  Google Scholar 

  • Gerich, J.E., Langlois, M., Noacco, C.: Glucagon secretion in obesity. Lancet 1973 I, 1323.

    Google Scholar 

  • Gerich, J.E., Langlois, M., Noacco, C., Karam, J.H., Forsham, P.H.: Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 182, 171–173(1973c).

    CAS  Google Scholar 

  • Gerich, J.E., Langlois, M., Schneider, V., Karam, J.H., Noacco, C.: Effects of alteration of plasma free fatty acid levels on pancreatic glucagon secretion in man. J. clin. Invest. 53,1284–1289(1974a).

    CAS  Google Scholar 

  • Gerich, J.E., Schneider, V., Dippe, S.E., Langlois, M., Noacco, C., Karam, J.H., Forsham, P.H.: Characterization of the glucagon response to hypoglycemia in man. J. clin. Endocr. 38, 77–82(1974b).

    CAS  Google Scholar 

  • Girard, J., Bal, D., Assan, R.: Glucagon secretion during the early postnatal period in the rat. Horm. metab. Res. 4, 168–170(1972).

    PubMed  CAS  Google Scholar 

  • Goldfine, I.D., Kirsteins, L., Lawrence, A.M.: Excessive glucagon responses to arginine in active acromegaly. Horm. metab. Res. 4, 97–100(1972).

    PubMed  CAS  Google Scholar 

  • Gomez-Acebo, J., Parrilla, R., Candela, J.L.R.: Fine structure of the A and D cells of the rabbit endocrine pancreas in vivo and incubated in vitro. I. Mechanism of secretion of the A cells. J. Cell Biol. 36, 33–44(1968).

    PubMed  CAS  Google Scholar 

  • Goodman, D.B.P., Rasmussen, H., Dibella, F., Guthrow, C.E.: Cyclic adenosine 3′ 4′-monophosphate stimulated phosphorylation of isolated neurotubule subunits. Proc. nat. Acad. Sci. (Wash.) 67, 652–659(1970).

    CAS  Google Scholar 

  • Grande, F.: Effect of glucagon on plasma free fatty acids and blood sugar in birds. Proc. Soc. exp. Biol. (N.Y.) 128, 532–536(1968).

    CAS  Google Scholar 

  • Grenier, J.F., Gillet, M., Kachelhoffer, J., Wong, P., Arriaga, R., Moody, A.J., Heding, L.G., Markussen, J., Sundby, F.: Circulation extra-corporelle d’intestin isole chez le chien. Mise en evidence d’une secretion par l’intestin de type glucagon. C.R. Soc. Biol. (Paris) 163, 2446–2449(1969).

    Google Scholar 

  • Grey, N., Mcguigan, J., Kipnis, D.: Neutralization of endogenous glucagon by high titer glucagon antiserum. Endocrinology 86, 1383–1388(1970).

    PubMed  CAS  Google Scholar 

  • Grodsky, G.M., Hayashida, T., Peng, C.T., Geschwind, I.I.: Production of glucagon antibodies and their role in metabolism and immunoassay of glucagon. Proc. Soc. exp. Biol. (N.Y.) 107, 491–494(1961).

    CAS  Google Scholar 

  • Grollman, A., Mccaleb, W.E., White, F.N.: Glucagon deficiency as a cause of hypoglycemia. Metabolism 13, 686–690(1964).

    PubMed  CAS  Google Scholar 

  • Guder, W., Frolich, J., Patzelt, C., Wieland, O.: The effect of glucagon on the state of lysosomal enzymes in isolated perfused rat liver. FEBS Letters 10, 215–218(1970).

    PubMed  CAS  Google Scholar 

  • Gutman, R.A., Fink, G., Voyles, N., Selawry, H., Penhos, J. C., Lepp, A., Recant, L.: Specific biologic effects of intestinal glucagon-like materials. J. clin. Invest. 52, 1165–1175(1973).

    PubMed  CAS  Google Scholar 

  • Hazzard, W.R., Crockford, P.M., Buchanan, K.D., Vance, J.E., Chen, R., Williams, R.H.: A double antibody immunoassay for glucagon. Diabetes 17, 179–186(1968).

    PubMed  CAS  Google Scholar 

  • Heding, L.G.: The production of glucagon antibodies in rabbits. Horm. Metab. Res. 1, 87–88(1969).

    PubMed  CAS  Google Scholar 

  • Heding, L.G.: Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabetologia 7, 10–19(1971).

    PubMed  CAS  Google Scholar 

  • Heding, L.G.: Immunologic properties of pancreatic glucagon: antigenicity and antibody characteristics. In: Glucagon, molecular physiology, clinical and therapeutic implications, P.J. Lefebvre and R.H. Unger, eds., p. 187–200. Oxford: Pergamon Press 1972.

    Google Scholar 

  • Heding, L.G., Rasmussen, S.M.: Determination of pancreatic and gut glucagon-like immunoreactivity (GLI) in normal and diabetic subjects. Diabetologia 8, 408–411(1972).

    PubMed  CAS  Google Scholar 

  • Hellerström, C., Hellman, B., Petersson, P., Alm, G.: The two types of pancreatic A-cells and their relation to glucagon secretion. In: The structure and metabolism of the pancreatic islets, S.E. Brolin, B. Hellman and H. Knutson, eds., p. 117–130. New York: Pergamon Press 1964.

    Google Scholar 

  • Hellerström, C., Howell, S.L., Edwards, J. C., Andersson, A.: An investigation of glucagon biosynthesis in isolated pancreatic islets of guinea-pigs. FEBS Letters 27, 97–101(1972).

    PubMed  Google Scholar 

  • Iversen, J.: Secretion of glucagon from the isolated, perfused canine pancreas. J. clin. Invest. 50, 2123–2136(1971).

    PubMed  CAS  Google Scholar 

  • Iversen, J.: Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas. J. clin. Invest. 52, 2102–2116(1973a).

    CAS  Google Scholar 

  • Iversen, J.: Effect of acetylcholine on the secretion of glucagon and insulin from the isolated perfused canine pancreas. Diabetes 22, 381–387(1973b).

    CAS  Google Scholar 

  • Jarousse, C., Rancon, F., Rosselin, G.: Hormonogenese perinatale de l’insuline et du glucagon chez le rat. C.R. Acad. Sci. (Paris) 276, 585–588(1973).

    Google Scholar 

  • Kalkhoff, R. K., Gossain, V. V., Matute, M.L.: Plasma glucagon in obesity. Response to arginine glucose and protein administration. New Engl. J. Med. 289, 465–467(1973).

    PubMed  CAS  Google Scholar 

  • Kaneto, A., Mizuno, Y., Tasaka, Y., Kosaka, K.: Stimulation of glucagon secretion by tetragastrin. Endocrinology 86, 1175–1180(1970).

    PubMed  CAS  Google Scholar 

  • Kenny, A.J., Say, R.R.: Glucagon-like activity extractable from the gastro-intestinal tract of man and other animals. J. Endocr. 25, 1–7(1962).

    PubMed  CAS  Google Scholar 

  • Kern, H.F.: The fine structure of pancreatic a-cells under normal and experimental conditions. In: The structure and metabolism of the pancreatic islets, S. Falkmer, B. Hellman and L.B. Täljedal, eds., p. 99–107. Oxford: Pergamon Press 1970.

    Google Scholar 

  • Kimball, C.P., Murlin, J. R.: Aqueous extracts of pancreas. III. Some precipitation reactions of insulin. J. biol. Chem. 58, 337–346(1923).

    CAS  Google Scholar 

  • Krug, E., Mialhe, P.: Pancreatic and intestinal glucagon in the duck. Horm. Metab. Res. 3, 24–27(1971).

    PubMed  CAS  Google Scholar 

  • Kuzuya, T., Kajinuma, H., Ide, T.: Effect of intrapancreatic injection of potassium and calcium on insulin and glucagon secretion in dogs. Diabetes 23, 55–60(1974).

    PubMed  CAS  Google Scholar 

  • Lacy, P.E.: Electron microscopy of the normal islets of Langerhans. Studies in the dog, rabbit, guinea-pig and rat. Diabetes 6, 498–507(1957).

    PubMed  CAS  Google Scholar 

  • Lange, R.: Immunofluoreszenzmikroskopische Darstellung glukagon-bildender Zellen an Plastikdimnschnitten von Inselgewebe (Ratte, Frosch). Histochemie 22, 226–233(1970).

    PubMed  CAS  Google Scholar 

  • Langslow, D.R., Hales, C.N.: Bioassay of glucagon in human serum. Lancet 1970 I, 1151–1152.

    Google Scholar 

  • Laube, H., Fussganger, R., Goberna, R., Schröder, K., Straub, K., Sussman, K., Pfeiffer, E.F.: Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas. Horm. Metab. Res. 3, 238–242(1971).

    PubMed  CAS  Google Scholar 

  • Lawrence, A.M.: Radioimmunoassayable glucagon levels in man: effects of starvation, hypoglycemia, and glucose administration. Proc. nat. Acad. Sci. (Wash.) 55, 316–320(1966).

    CAS  Google Scholar 

  • Lawrence, A.M.: Glucagon. Ann. Rev. Med. 20, 207–222(1969).

    PubMed  CAS  Google Scholar 

  • Lawrence, A.M.: Pancreatic alpha-cell function in miscellaneous clinical disorders. In: Glucagon, molecular physiology, clinical and therapeutic implications, P.J. Lefebvre and R.H. Unger, eds., p. 259–274. Oxford: Pergamon Press 1972.

    Google Scholar 

  • Lazarow, A.: Cell types of the islets of Langerhans and the hormones they produce. Diabetes 6, 222–233(1957).

    PubMed  CAS  Google Scholar 

  • Lazarus, S.S., Shapiro, S., Volk, B.W.: Secretory granule formation and release in rabbit pancreatic A-cells. Diabetes 17, 152–160(1968).

    PubMed  CAS  Google Scholar 

  • Leclercq-Meyer, V., Brisson, G.R., Malaisse, W. J.: Effect of epinephrine and glucose on glucagon and insulin release in vitro. Nature, (Lond.) New Biol. 231, 248–249(1971).

    CAS  Google Scholar 

  • Leclercq-Meyer, V., Marchand, J., Malaisse, W.J.: The effect of calcium and magnesium on glucagon secretion. Endocrinology 93, 1360–1370(1973).

    PubMed  CAS  Google Scholar 

  • Leclercq-Meyer, V., Mialhe, P., Malaisse, W.J.: Une methode de dosage radioimmunologique du glucagon compartant une separation par le charbon-dextran. Diabetologia 6, 121–129(1970).

    PubMed  CAS  Google Scholar 

  • Lefebvre, P.: The physiological effect of glucagon on fat mobilisation. Diabetologia 2, 130–132(1966).

    PubMed  CAS  Google Scholar 

  • Lefebvre, P.: Glucagon and lipid metabolism. In: Glucagon, molecular physiology, clinical and therapeutic implications, P.J. Lefebvre and R.H. Unger, eds., p. 109–121. Oxford: Pergamon Press 1972.

    Google Scholar 

  • Lefebvre, P. J., Unger, R.H., Valverde, I., Rigopoulou, D., Luyckx, A.S., Eisentraut, A.: Effect of dog jejunum “glucagon-like immunoreactive material” on adipose tissue metabolism. Horm. Metab. Res. 1, 143–144(1969).

    PubMed  CAS  Google Scholar 

  • Lightman, S.L., Bloom, S.R.: Cure of insulin-dependent diabetes mellitus by removal of a glucagonoma. Brit. med. J. 1974 I, 367–368.

    Google Scholar 

  • Like, A. A., Orci, L.: Embryogenesis of the human pancreatic islets: a light and electron microscopic study. Diabetes 21, 511–534(1972).

    PubMed  CAS  Google Scholar 

  • Lindsey, A., Santeusiano, F., Braaten, J., Faloona, G.R., Unger, R.H.: Pancreatic alpha-cell function in trauma. J. Amer. med. Ass. 227, 757–761(1974).

    CAS  Google Scholar 

  • Lomsky, R., Langr, F., Vortel, V.: Site of glucagon in the islets of Langerhans of man as studied by the immunofluorescent technic. Sborn. lek. 11, 585–595(1968).

    CAS  Google Scholar 

  • Lomsky, R., Langr, F., Vortel, V.: Demonstration of glucagon in islet cell adenomas of the pancreas by immunofluorescent technic. Amer. J. clin. Path. 51, 245–250(1969).

    CAS  Google Scholar 

  • Luyckx, A.S.: Immunoassays for glucagon. In: Glucagon, molecular physiology, clinical and therapeutic implications, P.J. Lefebvre and R.H. Unger, eds., p. 285–298, Oxford: Pergamon Press, 1972.

    Google Scholar 

  • Luyckx, A.S., Lefebvre, P.J.: Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids. Proc. Soc. exp. Biol. (N.Y.) 133, 524–528(1970).

    CAS  Google Scholar 

  • Luyckx, A.S., Lefebvre, P.J.: Mechanisms involved in the exercise-induced increase in glucagon secretion in rats. Diabetes 23, 81–93(1974a).

    CAS  Google Scholar 

  • Luyckx, A., Lefebvre, P.: The role of energy substrates in controlling glucagon secretion. Experimental studies. In: Diabetes, Proc. 8th Congr. Int. Diab. Fed., Brussels 1973, p. 190–202. Amsterdam: Excerpta Medica, ICS n° 312, 1974b.

    Google Scholar 

  • Machino, M., Sakuma, H.: Electron microscopy of islet alpha cells of domestic fowl. Nature (Lond.) 214, 808–809(1967).

    CAS  Google Scholar 

  • Madison, L.L., Seyffert, W.A., jr., Unger, R.H., Barker, B.: Effect of plasma free fatty acids on plasma glucagon and serum insulin concentrations. Metabolism 17, 301–304(1968).

    PubMed  CAS  Google Scholar 

  • Makman, M.H., Sutherland, E.W., jr.: Use of liver adenyl cyclase for assay of glucagon in human gastro-intestinal tract and pancreas. Endocrinology 75, 127–134(1964).

    PubMed  CAS  Google Scholar 

  • Malaisse, W.J.: Hormonal and environmental modification of islet activity. In: Handbook of physiology, section 7: Endocrinology, vol. I: Endocrine pancreas, D. Steiner and N. Freinkel, eds., p. 237–260. Washington: American Physiological Society 1972.

    Google Scholar 

  • Malaisse, W., Malaisse-Lagae, F., King, S.: Effects of neutral red and imidazole upon insulin secretion. Diabetologia 4, 370–374(1968).

    PubMed  CAS  Google Scholar 

  • Marco, J., Baroja, I.M., Diaz-Fierros, M., Villanueva, M.L., Valverde, I.: Relationship between insulin and gut glucagon-like immunoreactivity (GLI) secretion in normal and gastrectomized subjects. J. clin. Endocr. 34, 188–191(1972).

    PubMed  CAS  Google Scholar 

  • Marco, J., Calle, C., Roman, D., Diaz-Fierros, M., Villanueva, M.L., Valverde, I.: Hyperglucagonism induced by glucocorticoid treatment in man. New Engl. J. Med. 288, 128–131 (1973a).

    CAS  Google Scholar 

  • Marco, J., Diego, J., Villanueva, M.L., Diaz-Fierros, M., Valverde, L, Segovia, J.M.: Elevated plasma glucagon levels in cirrhosis of the liver. New Engl. J. Med. 289, 1107–1111(1973b).

    CAS  Google Scholar 

  • Marco, J., Faloona, G.R., Unger, R.H.: The glycogenolytic activity of immunoreactive glucagon in plasma. J. clin. Invest. 50, 1650–1655(1971).

    PubMed  CAS  Google Scholar 

  • Marco, J., Valverde, I.: Unaltered glucagon secretion after seven days of sulfonylurea administration in normal subjects. Diabetologia 9, Suppl., 317–319(1973).

    CAS  Google Scholar 

  • Markussen, J., Frandsen, E., Heding, L.G., Sundby, F.: Turkey glucagon: crystallization, amino acid composition and immunology. Horm. Metab. Res. 4, 360–363(1972).

    PubMed  CAS  Google Scholar 

  • Marliss, E.B., Aoki, T.T., Cahill, G.F., jr.: Glucagon and amino-acid metabolism. In: Glucagon, molecular physiology, clinical and therapeutic implications, P.J. Lefebvre and R.H. Unger, eds., p. 123–150. Oxford: Pergamon Press 1972.

    Google Scholar 

  • Marliss, E.B., Aoki, T.T., Unger, R.H., Soeldner, J.S., Cahill, G.F., jr.: Glucagon levels and metabolic effects in fasting man. J. clin. Invest. 49, 2256–2270(1970).

    PubMed  CAS  Google Scholar 

  • Marliss, E.B., Girard, L., Seydoux, J., Wollheim, C.B., Kanazawa, Y., Orci, L., Renold, A.E., Porte, D., jr.: Glucagon release induced by pancreatic stimulation in the dog. J. clin. Invest. 52, 1246–1259(1973a).

    CAS  Google Scholar 

  • Marliss, E.B., Wollheim, C.B., Blondel, B., Orci, L., Lambert, A.E., Stauffacher, W., Like, A., Renold, A.E.: Insulin and glucagon release from monolayer cell cultures of pancreas from newborn rats. Europ. J. clin. Invest. 3, 16–26(1973b).

    CAS  Google Scholar 

  • McGavran, M.H., Unger, R.H., Recant, L., Polk, H. C., Kilo, C., Levin, M.E.: A glucagonsecreting alpha-cell carcinoma of the pancreas. New Engl. J. Med. 274, 1408–1413(1966).

    PubMed  CAS  Google Scholar 

  • McQuarrie, I., Bell, E.T., Zimmermann, B., Wright, W. S.: Deficiency of alpha cells of pancreas as possible ethiological factor in familial hypoglycemosis. Fed. Proc. 9, 337(1950).

    Google Scholar 

  • Mialhe, P.: Glucagon, insuline et regulation endocrine de la glycemie chez le canard. Acta endocr. (Kbh.), Suppl. 36, 1–134(1958).

    Google Scholar 

  • Miller, L.L.: Direct actions of insulin, glucagon and epinephrine on the isolated perfused rat liver. Fed. Proc. 24, 737–744(1965).

    PubMed  CAS  Google Scholar 

  • Moody, A.J., Markussen, J., Schaich Fries, A., Steenstrup, C., Sundby, F., Malaisse, W., Malaisse-Lagae, F.: The insulin releasing activities of extracts of pork intestine. Diabetologia 6, 135–140(1970).

    PubMed  CAS  Google Scholar 

  • Müller, W. A., Faloona, G.R., Aguilar-Parada, E., Unger, R.H.: Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. New Engl. J. Med. 283, 109–115(1970).

    PubMed  Google Scholar 

  • Müller, W.A., Faloona, G.R., Unger, R.H.: The effect of alanine on glucagon secretion. J. clin. Invest. 50, 2215–2218(1971).

    PubMed  Google Scholar 

  • Munger, B. L.: The secretory cycle of the pancreatic islet a-cell. An electron microscopic study of normal and synthalin-treated rabbits. Lab. Invest. 11, 885–901(1962).

    PubMed  CAS  Google Scholar 

  • Noe, B.D., Bauer, G.E.: Evidence for glucagon biosynthesis involving a protein intermediate in islets of the Anglerfish (Lophius americanus). Endocrinology 89, 642–651(1971).

    PubMed  CAS  Google Scholar 

  • Noe, B.D., Bauer, G.E.: Further characterization of a glucagon precursor from Anglerfish islet tissue. Proc. Soc. exp. Biol. (N.Y.) 142, 210–213(1973).

    CAS  Google Scholar 

  • Nonaka, K., Foa, P.P.: A simplified glucagon immunoassay and its use in a study of incubated pancreatic islets. Proc. Soc. exp. Biol. (N.Y.) 130, 330–336(1969).

    CAS  Google Scholar 

  • Ohneda, A., Aguillar-Parada, E., Eisentraut, A.M., Unger, R.H.: Control of pancreatic glucagon secretion by glucose. Diabetes 18, 1–10(1969).

    PubMed  CAS  Google Scholar 

  • Ohneda, A., Parada, E., Eisentraut, A.M., Unger, R.H.: Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids. J. clin. Invest. 47, 2305–2322(1968).

    PubMed  CAS  Google Scholar 

  • Okada, N., Takaki, R., Kitagawa, M.: Histologie and immunofluorescent studies on the site of origin of glucagon in mammalian pancreas. J. Histochem. Cytochem. 16, 405–409(1968).

    PubMed  CAS  Google Scholar 

  • Orci, L., Lambert, A.E., Rouiller, C., Renold, A.E., Samols, E.: Evidence for the presence of A-cells in the endocrine fetal pancreas of the rat. Horm. Met. Res. 1, 108–110(1969).

    CAS  Google Scholar 

  • Orci, L., Pictet, R., Forssmann, W. G., Renold, A.E., Rouiller, C.: Structural evidence for glucagon producing cells in the intestinal mucosa of the rat. Diabetologia 4, 56–67(1968).

    PubMed  CAS  Google Scholar 

  • Paloyan, E., Paloyan, D., Harper, P.V.: The role of glucagon hypersecretion in the relationship of pancreatitis and hyperparathyroidism. Surgery 62, 167–173(1967).

    Google Scholar 

  • Park, C.R., Exton, J. H.: Glucagon and the metabolism of glucose. In: Glucagon, molecular physiology, clinical and therapeutic implications, P. J. Lefebvre and R.H. Unger, eds. p. 77–108. Oxford: Pergamon Press 1972.

    Google Scholar 

  • Pearce, A.G.E., Polak, J.M., Heath, C.M.: Development, differentiation and derivation of the endocrine polypeptide cells of the mouse pancreas. Immunofluorescence, cytochemical and ultrastructural studies. Diabetologia 9, 120–129(1973).

    Google Scholar 

  • Pek, S., Fajans, S.S., Floyd, J. C., Jr., Knopf, R.F.: Clinical conditions with elevated plasma levels of glucagon. In: Diabetes, Proc. 8th Congr. Int. Diabetes Fed., Brussels 1973, p. 207–213. Amsterdam: Excerpta medica, ICS n° 312, 1974.

    Google Scholar 

  • Pek, S., Fajans, S.S., Floyd, J. C., jr., Knopf, F.R., Conn, J. W.: Failure of sulfonylureas to suppress plasma glucagon in man. Diabetes 21, 216–223(1972).

    PubMed  CAS  Google Scholar 

  • Perrier, H., Billat, C.: Evolution de l’ulstrastructure du pancreas chez le foetus de rat. Diabetologia 6, 605–615(1970).

    PubMed  CAS  Google Scholar 

  • Perrier, H., Porte, A., Jacquot, R.: Presence de cellules A dans le pancreas foetal de rat. C.R. Acad. Sci., serie D, 269, 841–843(1969).

    Google Scholar 

  • Persson, I., Gyntelberg, F., Heding, L.G., Boss-Nielsen, J.: Pancreatic glucagon-like immunoreactivity after intravenous insulin in normal and chronic-pancreatitis patients. Acta endocr. (Kbh.) 67, 401–404(1971).

    CAS  Google Scholar 

  • Petersson, B.: The two types of alpha cells during the development of the guinea-pig pancreas. Z. Zellforsch. 75, 371–380(1966).

    PubMed  CAS  Google Scholar 

  • Petersson, B., Hellman, B.: Effects of long term administration of glucagon on the pancreatic islet tissue of rats and guinea-pigs. Acta endocr. (Kbh.) 44, 139–149(1963).

    CAS  Google Scholar 

  • Pictet, R., Rutter, W. J.: Development of the embryonic endocrine pancreas. In: Handbook of physiology, section 7: Endocrinology, vol. I: Endocrine pancreas, D.F. Steiner and N. Freinkel, eds., p. 25–66. Washington: American Physiological Society 1972.

    Google Scholar 

  • Pincus, I.J., Rutman, J.Z.: Glucagon, the hyperglycemic agent in pancreatic extracts. Arch. intern. Med. 92, 666–677(1953).

    CAS  Google Scholar 

  • Rabinovitch, A., Dupre, J.: Effects of the gastric inhibitory polypeptide present in impure pancreozymin-cholecystokinin on plasma insulin and glucagon in the rat. Endocrinology 94, 1139–1144(1974).

    PubMed  CAS  Google Scholar 

  • Rasmussen, H., Tenenhouse, A.: Cyclic adenosine monophosphate, Ca++, and membranes. Proc. nat. Acad. Sci. (Wash.) 59, 1364–1370(1968).

    CAS  Google Scholar 

  • Rehfeld, J.F., Heding, L.G.: Increased release of gut glucagon in reactive hypoglycaemia. Brit. med. J. 1970 II, 706–707.

    Google Scholar 

  • Rigopoulou, D., Valverde, I., Marco, J., Faloonga, G., Unger, R.H.: Large glucagon immunoreactivity in extracts of pancreas. J. biol. Chem. 245, 496–501(1970).

    PubMed  CAS  Google Scholar 

  • Rocha, D.M., Faloona, G.R., Unger, R.H.: Glucagon-stimulating activity of 20 amino-acids in dogs. J. clin. Invest. 51, 2346–2351(1972).

    PubMed  CAS  Google Scholar 

  • Rocha, D.M., Santeusiano, F., Faloona, G.R., Unger, R.H.: Abnormal pancreatic alpha-cell function in bacterial infections. New Engl. J. Med. 288, 700–703(1973).

    PubMed  CAS  Google Scholar 

  • Rodbell, M.: Regulation of glucagon action at its receptors. In: Glucagon, molecular physiology, clinical and therapeutic implications, P.J. Lefebvre and R.H. Unger, eds., p. 61–75. Oxford: Pergamon Press 1972.

    Google Scholar 

  • Rodbell, M., Birnbaumer, L., Pohl, S.L., Michiel, H., Krans, J.: Properties of the adenyl cyclase systems in liver and adipose cells: the mode of action of hormones. In: On the pathogenesis of diabetes mellitus, R. Luft and P.J. Randle, eds., p. 9–57. Milano: Casa Editrice „Il ponte“ 1970.

    Google Scholar 

  • Samols, E., Marks, V.: Nouvelles conceptions sur la signification fonctionnelle du glucagon (pancreatique et extrapancreatique). In: Journees Annuelles de Diabetologie de l’Hotel Dieu, p. 43–66. Paris: Editions Medicales Flammarion 1967.

    Google Scholar 

  • Samols, E., Marri, G., Marks, V.: Promotion of insulin secretion by glucagon. Lancet 1965a II, 415–416.

    Google Scholar 

  • Samols, E., Tyler, J.M., Marks, V.: Glucagon-insulin relationships. In: Glucagon, molecular physiology, clinical and therapeutic implications, P.J. Lefebvre and R.H. Unger, eds., p. 151–173. Oxford: Pergamon Press 1972.

    Google Scholar 

  • Samols, E., Tyler, J., Marri, G., Marks, V.: Stimulation of glucagon secretion by oral glucose. Lancet 1965b II, 1257–1259.

    Google Scholar 

  • Samols, E., Tyler, J., Megyesi, C., Marks, V.: Immunochemical glucagon in human pancreas, gut, and plasma. Lancet 1966 II, 727–729.

    Google Scholar 

  • Samols, E., Tyler, J.M., Mialhe, P.: Suppression of pancreatic glucagon release by the hypoglycaemic sulfonylureas. Lancet 1969 I, 174–176.

    CAS  Google Scholar 

  • Santeusiano, F., Faloona, G.R., Knockel, J.P., Unger, R.H.: Evidence for a role of endogenous insulin and glucagon in the regulation of potassium homeostasis. J. Lab. clin. Med. 81, 809–817(1973a).

    Google Scholar 

  • Santeusiano, F., Faloona, G.R., Unger, R.H.: Suppressive effect of secretin upon pancreatic alpha cell function. J. clin. Invest. 51, 1743–1749(1972).

    Google Scholar 

  • Santeusiano, F., Faloona, G.R., Unger, R.H.: Inhibition of alanine-stimulated glucagon secretion by secretin in the dog. Horm. Metab. Res. 5, 425–427(1973b).

    Google Scholar 

  • Sato, T., Herman, L., Fitzgerald, P.J.: The comparative ultrastructure of the pancreatic islet of Langerhans. Gen. comp. Endocr. 7, 132–157(1966).

    Google Scholar 

  • Schopman, W., Hackeng, W.H.L., Steendijk, C.: The purification of 125I-glucagon of high specific activity for radioimmunochemical estimation of glucagon and a qualitative comparison of glucagon from different sources. Acta endocr. (Kbh.) 54, 527–540(1967).

    CAS  Google Scholar 

  • Shima, K., Foa, P.P.: A double antibody assay for glucagon. Clin. chim. Acta 22, 511–520(1968).

    PubMed  CAS  Google Scholar 

  • Sokal, J.E.: Effect of glucagon on gluconeogenesis by the isolated perfused rat liver. Endocrinology 78, 538–548(1966a).

    CAS  Google Scholar 

  • Sokal, J.E.: Glucagon. An essential hormone. Amer. J. Med. 41, 331–341(1966b).

    CAS  Google Scholar 

  • Sokal, J.E.: Bioassays for glucagon. In: Glucagon, molecular physiology, clinical and therapeutic implications, P.J. Lefebvre and R.H. Unger, eds., p. 275–284. Oxford: Pergamon Press 1972.

    Google Scholar 

  • Sokal, J.E., Ezdinli, E.Z.: Basal plasma glucagon levels of man. J. clin. Invest. 46, 778–785(1967).

    PubMed  CAS  Google Scholar 

  • Sokal, J.E., Sarcione, E.J., Henderson, A.M.: Relative potency of glucagon and epinephrine as hepatic glycogenolytic agents: studies with the isolated perfused rat liver. Endocrinology 74, 930–938(1964).

    PubMed  CAS  Google Scholar 

  • Sperling, M.A., Lamater, P.V., de, Phelps, D., Fiser, R.H., Oh, W., Fisher, D.A.: Spontaneous and amino acid-stimulated glucagon secretion in the immediate postnatal period. Relation to glucose and insulin. J. clin. Invest. 53, 1159–1166(1974).

    PubMed  CAS  Google Scholar 

  • Staub, A., Sinn, L., Behrens, O. K.: Purification and crystallization of glucagon. J. biol. Chem. 214, 619–632(1955).

    PubMed  CAS  Google Scholar 

  • Struck, E., Ashmore, J., Wieland, O.: Stimulierung der Gluconeogenese durch langkettige Fettsäuren und Glucagon. Biochem. Z. 343, 107–110(1965).

    PubMed  CAS  Google Scholar 

  • Sundby, F., Markussen, J.: Isolation crystallization and amino acid composition of rat glucagon. Horm. Metab. Res. 3, 184–187(1971).

    PubMed  CAS  Google Scholar 

  • Sundby, F., Markussen, J.: Rabbit glucagon: isolation crystallization and amino acid composition. Horm. Metab. Res. 4, 56(1972).

    PubMed  CAS  Google Scholar 

  • Sutherland, E.W., Cori, C.F., Haynes, R., Olsen, N.S.: Purification of the hyperglycemicglycogenolytic factor from insulin and from gastric mucisa. J. biol. Chem. 180, 825–837 (1949).

    PubMed  CAS  Google Scholar 

  • Sutherland, E.W., Duve, C. de: Origin and distribution of the hyperglycemic-glycogenolytic factor of the pancreas. J. biol. Chem. 175, 663–674(1948).

    PubMed  CAS  Google Scholar 

  • Sutherland, E.W., Hardman, J.G., Butcher, R.W., Broadus, A.E.: The biological role of cyclic AMP (some areas of contrast with cyclic GMP). In: Progress in endocrinology, C. Gual, ed., p. 26–32. Amsterdam: Excerpta Medica Foundation, ICS n° 184, 1968.

    Google Scholar 

  • Tager, H.S., Steiner, D.F.: Isolation of a glucagon-containing peptide: primary structure of a possible fragment of proglucagon. Proc. nat. Acad. Sci. (Wash.) 70, 2321–2325(1973).

    CAS  Google Scholar 

  • Thomsen, J., Kristiansen, K., Brunfeldt, K., Sundby, F.: The amino acid sequence of human glucagon. FEBS Letters 21, 315–319(1972).

    PubMed  CAS  Google Scholar 

  • Tung, A. K.: Biosynthesis of avian glucagon: evidence for a possible high molecular weight biosynthetic intermediate. Horm. Metab. Res. 5, 416–424(1973).

    PubMed  CAS  Google Scholar 

  • Tung, A. K., Zerega, F.: Biosynthesis of glucagon in isolated pigeon islets. Biochem. biophys. Res. Commun. 45, 387–395(1971).

    PubMed  CAS  Google Scholar 

  • Unger, R.H.: Glucagon and the insulin: glucagon ratio in diabetes and other catabolic illnesses. Diabetes 20, 834–838(1971).

    PubMed  CAS  Google Scholar 

  • Unger, R.H.: Glucagon and glucagon immunoreactivity in plasma and pancreatic tissues. In: Glucagon, molecular physiology, clinical and therapeutic implications, P.J. Lefebvre and R.H. Unger, eds. p. 205–211. Oxford: Pergamon Press 1972a.

    Google Scholar 

  • Unger, R.H.: Pancreatic alpha-cell function in diabetes mellitus. In: Glucagon, molecular physiology, clinical and therapeutic implications, P.J. Lefebvre and R.H. Unger, eds., p. 245–257. Oxford: Pergamon Press 1972b.

    Google Scholar 

  • Unger, R.H.: Radioimmunoassay of glucagon. Metabolism 22, 979–985(1973a).

    CAS  Google Scholar 

  • Unger, R.H.: Normal and abnormal alpha cell function. Ann. Rev. Med. 24, 303–308(1973b).

    CAS  Google Scholar 

  • Unger, R.H., Aguilar-Parada, E., Müller, W.A., Eisentraut, A.M.: Studies of pancreatic alpha cell function in normal and diabetic subjects. J. clin. Invest. 49, 837–848(1970).

    PubMed  CAS  Google Scholar 

  • Unger, R.H., Eisentraut, A.M.: Glucagon. In: Hormones in blood, C.H. Gray and A.L. Bucharach, eds., 2nd ed., vol. I, p. 83–128. London-New York: Academic Press 1967.

    Google Scholar 

  • Unger, R.H., Eisentraut, A.M.: Entero-insular axis. Arch. intern. Med. 123, 261–266(1969).

    PubMed  CAS  Google Scholar 

  • Unger, R.H., Eisentraut, A.M., McCall, M.S., Keller, S., Lanz, H.C., Madison, L.L.: Glucagon antibodies and their use for immunoassay for glucagon. Proc. Soc. exp. Biol. (N.Y.) 102, 621–623(1959).

    CAS  Google Scholar 

  • Unger, R.H., Eisentraut, A.M., McCall, M.S., Madison, L.L.: Glucagon antibodies and an immunoassay for glucagon. J. clin. Invest. 40, 1280–1289(1961).

    PubMed  CAS  Google Scholar 

  • Unger, R.H., Ketterer, H., Dupre, J., Eisentraut, A.M.: The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs. J. clin. Invest. 46, 630–645(1967).

    PubMed  CAS  Google Scholar 

  • Unger, R.H., Ketterer, H., Eisentraut, A.M.: Distribution of immunoassayable glucagon in gastrointestinal tissues. Metabolism 15, 865–867(1966).

    PubMed  CAS  Google Scholar 

  • Unger, R.H., Lefebvre, P.J.: Glucagon physiology. In: Glucagon, molecular physiology, clinical and therapeutic implications, P.J. Lefebvre and R.H. Unger, eds., p. 213–244. Oxford: Pergamon Press 1972.

    Google Scholar 

  • Unger, R.H., Lochner, J.V. de., Eisentraut, A.M.: Identification of insulin and glucagon in a bronchogenic metastasis. J. clin. Endocr. 24, 823–831(1964).

    PubMed  CAS  Google Scholar 

  • Unger, R.H., Madison, L.L., Müller, W. A.: Abnormal alpha cell function in diabetics: response to insulin. Diabetes 21, 301–307(1972).

    Google Scholar 

  • Unger, R.H., Ohneda, A., Aguilar-Parada, E., Eisentraut, A.M.: The role of aminogenic glucagon secretion in blood glucose homeostasis. J. clin. Invest. 48, 810–822(1969).

    PubMed  CAS  Google Scholar 

  • Unger, R.H., Ohneda, A., Valverde, I., Eisentraut, A.M., Exton, J.: Characterization of the responses of circulating glucagon like immunoreactivity to intraduodenal and intravenous administration of glucose. J. clin. Invest. 47, 48–65(1968).

    PubMed  CAS  Google Scholar 

  • Valverde, I., Rigopoulou, D., Exton, J., Ohneda, A., Eisentraut, A.M., Unger, R.H.: Demonstration and characterization of a second fraction of glucagon-like immunoreactivity in jejunal extracts. Amer. J. med. Sci. 255, 415–420(1968).

    PubMed  CAS  Google Scholar 

  • Valverde, I., Rigopoulou, D., Marco, J., Faloona, G.R., Unger, R.H.: Characterization of glucagon-like immunoreactivity (GLI). Diabetes 19, 614–623(1970).

    PubMed  CAS  Google Scholar 

  • Vance, J.E., Buchanan, K.D., Challoner, D.R., Williams, R.H.: Effect of glucose concentration on insulin and glucagon release from isolated islets of Langerhans of the rat. Diabetes 17, 187–193(1968).

    PubMed  CAS  Google Scholar 

  • Vance, J.E., Buchanan, K.D., Williams, R.H.: Glucagon and insulin release. Influence of drugs affecting the autonomic nervous system. Diabetes 20, 78–82(1971).

    PubMed  CAS  Google Scholar 

  • Vance, J.E., Stoll, R. W., Kitabchi, A.E., Williams, R.H., Wood, F. C., jr.: Nesidioblastosis in familial endocrine adenomatosis. J. Amer. med. Ass. 207, 1679–1682(1969).

    CAS  Google Scholar 

  • Walsh, D.A., Krebs, E.G., Reimann, E.M., Brostrom, M.A., Corbin, J.D., Hickenbottom, J.P., Soderling, T.R., Perkins, J.P.: The receptor protein for cyclic AMP in the control of glycogenos is. In: Role of cyclic AMP in cell function, P. Greengard and E. Costa, eds., p. 265–285. New York: Raven Press 1970.

    Google Scholar 

  • Weinges, K. F.: Glucagon. In: Monographic in der Reihe Biochemie und Klinik, Hrsg. G. Weitzel und N. Zöllner. Stuttgart: Georg Thieme Verlag 1968.

    Google Scholar 

  • Weintraub, B., Sarcione, E.J., Sokal, J.E.: Effect of glucagon on phosphorylase activity of the isolated perfused rat liver. Amer. J. Physiol. 216, 521–526(1969).

    PubMed  CAS  Google Scholar 

  • Wellman, K. F., Volk, B.W., Brancato, P.: Ultrastructure and insulin content of the endocrine pancreas in the human fetus. Lab. Invest. 25, 97–103(1971).

    Google Scholar 

  • Williamson, J.R., Wright, P.H., Malaisse, W. J., Ashmore, J.: Control of glucogenesis by acetyl CoA in rats treated with glucagon and anti-insulin serum. Biochem. biophys. Res. Commun. 24, 765–770(1966).

    CAS  Google Scholar 

  • Wilmore, D., Moylan, J.A., Pruitt, B.A., Lindsey, C.A., Faloona, G.R., Unger, R.H.: Hyperglucagonemia after burns. Lancet 1974 I, 73–74.

    Google Scholar 

  • Winborn, W. B.: Light and electron microscopy of the islets of Langerhans of the Saimiri Monkey pancreas. Anat. Rec. 147, 65–93(1963).

    PubMed  CAS  Google Scholar 

  • Wise, J.K., Hendler, R., Felig, P.: Obesity: evidence for decreased secretion of glucagon. Science 178, 513–514(1972).

    PubMed  CAS  Google Scholar 

  • Wise, J.K., Hendler, R., Felig, P.: Evaluation of alpha-cell function by infusion of alanine in normal, diabetic and obese subjects. New Engl. J. Med. 288, 484–487(1973a).

    Google Scholar 

  • Wise, J.K., Hendler, R., Felig, P.: Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man. J. clin. Invest. 52, 2774–2782(1973b).

    CAS  Google Scholar 

  • Worobec, R., Locke, R., Hall, A., Ertl, R., Ernst, K., Deininger, E.: Production of antibodies of high binding affinities to glucagon in rabbits. Biochem. biophys. Res. Commun. 29, 406–412(1967).

    PubMed  CAS  Google Scholar 

  • Wunsch, E.: Die Totalsynthese des Pankreas-Hormons Glucagon. Z. Naturforsch. 22b, 1269–1276(1967).

    Google Scholar 

  • Wunsch, E., Weinges, K. F.: The synthesis of glucagon. Properties of synthetic glucagon. In: Glucagon, molecular physiology, clinical and therapeutic implications, P.J. Lefebvre and R.H. Unger, eds., p. 31–46. Oxford: Pergamon Press 1972.

    Google Scholar 

  • Wulf, H., de: The control of glycogen metabolism in the liver. Louvain: Vander 1971.

    Google Scholar 

  • Yoshinaga, T., Okuno, G., Shinji, Y., Tsujii, T., Nishikawa, M.: Pancreatic A-cell tumor associated with severe diabetes mellitus. Diabetes 15, 709–713(1966).

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1975 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Leclercq-Meyer, V., Malaisse, W.J. (1975). Die Stoffwechselwirkungen des Glukagon. In: Cerasi, E., et al. Diabetes mellitus · A. Handbuch der inneren Medizin, vol 7 / 2 / A. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66033-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-66033-7_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-66034-4

  • Online ISBN: 978-3-642-66033-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics